Michael Terrence Gibbs, General Counsel at T2 Biosystems, Inc. (TTOO), sold 7,280 shares at $2.06 ($15K) on 2021-02-23, disclosed to the SEC on 2021-02-23.
Scheduled sale ($15k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTOO | BUY | 2022-04-11 | $5K | — | Filing → |
| TTOO | SELL | 2021-03-25 | $14K | — | Filing → |
| TTOO | SELL | 2020-02-25 | $5K | — | Filing → |